BridgeBio Pharma, Inc. financial data

Symbol
BBIO on Nasdaq
Location
Palo Alto, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 24 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 390% % -13%
Quick Ratio 8.8% %
Debt-to-equity -152% % 8.5%
Operating Margin -104% % 61%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 193,862,871 shares 1.9%
Common Stock, Shares, Outstanding 194,771,957 shares 2.5%
Entity Public Float $7,300,000,000 USD 96%
Common Stock, Value, Issued $202,000 USD 3.1%
Weighted Average Number of Shares Outstanding, Basic 191,527,482 shares 2.9%
Weighted Average Number of Shares Outstanding, Diluted 191,527,482 shares 2.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $502,076,000 USD 126%
Cost of Revenue $20,962,000 USD 441%
Research and Development Expense $451,953,000 USD -11%
Costs and Expenses $1,025,487,000 USD 26%
Operating Income (Loss) $523,411,000 USD 12%
Nonoperating Income (Expense) $209,092,000 USD -512%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $186,482,000 USD -14%
Income Tax Expense (Benefit) $435,000 USD -62%
Earnings Per Share, Basic -3.78 USD/shares -31%
Earnings Per Share, Diluted -3.78 USD/shares -31%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $570,119,000 USD -16%
Marketable Securities, Current $7,939,000 USD -80%
Accounts Receivable, after Allowance for Credit Loss, Current $139,444,000 USD 2853%
Inventory, Net $26,753,000 USD
Assets, Current $797,749,000 USD 11%
Property, Plant and Equipment, Net $5,366,000 USD -23%
Operating Lease, Right-of-Use Asset $8,149,000 USD 41%
Intangible Assets, Net (Excluding Goodwill) $28,077,000 USD 17%
Other Assets, Noncurrent $16,712,000 USD -8.2%
Assets $936,025,000 USD 1.8%
Accounts Payable, Current $36,228,000 USD 277%
Employee-related Liabilities, Current $76,703,000 USD 32%
Contract with Customer, Liability, Current $7,190,000 USD -51%
Liabilities, Current $287,971,000 USD 87%
Contract with Customer, Liability, Noncurrent $13,080,000 USD -23%
Operating Lease, Liability, Noncurrent $3,811,000 USD -19%
Other Liabilities, Noncurrent $244,000 USD -15%
Liabilities $3,012,606,000 USD 27%
Accumulated Other Comprehensive Income (Loss), Net of Tax $12,000 USD 50%
Retained Earnings (Accumulated Deficit) $3,821,194,000 USD -23%
Stockholders' Equity Attributable to Parent $2,086,610,000 USD -42%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2,076,011,000 USD -42%
Liabilities and Equity $936,025,000 USD 1.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $199,235,000 USD 9.2%
Net Cash Provided by (Used in) Financing Activities $60,328,000 USD -78%
Net Cash Provided by (Used in) Investing Activities $1,595,000 USD -107%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 202,369,129 shares 3.1%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $140,502,000 USD -270%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $572,140,000 USD -16%
Interest Paid, Excluding Capitalized Interest, Operating Activities $23,271,000 USD -34%
Deferred Tax Assets, Valuation Allowance $968,021,000 USD 33%
Deferred Tax Assets, Gross $969,572,000 USD 33%
Operating Lease, Liability $10,003,000 USD 8.7%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $724,927,000 USD -35%
Lessee, Operating Lease, Liability, to be Paid $10,873,000 USD 7.6%
Operating Lease, Liability, Current $6,192,000 USD 37%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,320,000 USD -47%
Lessee, Operating Lease, Liability, to be Paid, Year One $6,642,000 USD 35%
Operating Lease, Weighted Average Discount Rate, Percent 0.068 pure 13%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $870,000 USD -3.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three $976,000 USD 124%
Deferred Tax Assets, Operating Loss Carryforwards $490,732,000 USD 29%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25,000,000 shares 0%
Unrecognized Tax Benefits $43,979,000 USD 19%
Lessee, Operating Lease, Liability, to be Paid, Year Four $494,000 USD 13%
Operating Lease, Payments $1,470,000 USD -7.8%
Additional Paid in Capital $2,057,646,000 USD 8.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $2,700,000 USD 12%
Depreciation, Depletion and Amortization $1,284,000 USD -20%
Deferred Tax Assets, Net of Valuation Allowance $1,551,000 USD 18%
Share-based Payment Arrangement, Expense $136,882,000 USD 20%
Interest Expense $86,982,000 USD 8%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%